跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AT-247
首页
药物
AT-247
AT-247
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
ISOLATED POLYNUCLEOTIDES AND POLYPEPTIDES, AND METHODS OF USING SAME FOR INCREASING PLANT YIELD AND/OR AGRICULTURAL CHARACTERISTICS
EP 3862433 A3
申请人: EVOGENE LTD
优先权: 2009
EP
US
3 件公开
Multiply-substituted protease variants
US 2003073222 A1
申请人: POULOSE AYROOKARAN J
优先权: 2001
US
2 件公开
Matrix metalloproteinase inhibitors
US 2003078276 A1
申请人: ANDRIANJARA CHARLES
优先权: 2002
US
2 件公开
Bleaching compositions comprising multiply-substituted protease variants
US 6831053 B1
申请人: PROCTER & GAMBLE
优先权: 2000
US
Variant Fc regions
US 7740847 B2
申请人: APPLIED MOLECULAR EVOLUTION
优先权: 2005
US
DETERMINATION OF IMMUNOGLOBULIN ENCODING NUCLEIC ACID
US 2011229903 A1
申请人: GOEPFERT ULRICH
优先权: 2008
US
POLYPEPTIDE FOR THE HYDROLYTIC CLEAVAGE OF ZEARALENONE AND/OR ZEARALENONE DERIVATIVES, ISOLATED POLYNUCLEOTIDE THEREOF, AND ADDITIVE CONTAINING POLYPEPTIDE, USE OF SAID POLYPEPTIDE AND METHOD
WO 2015027259 A2
申请人: ERBER AKTIENGESELLCHAFT
优先权: 2013
WO
COMPOSITION FOR IMPROVING SKIN CONDITION CONTAINING PLANT EXTRACTS
EP 3991801 A1
申请人: UAB BIOKLINIKA
优先权: 2020
EP
LIGHT-RESPONSIVE PROTEIN FOR COLOR RECOGNITION AND USE THEREOF
EP 4119666 A4
申请人: NAGOYA INST TECH
优先权: 2021
EP
CHIMERIC CYTOKINE RECEPTOR
US 2024352088 A1
申请人: AICHI PREFECTURE
优先权: 2021
US
第 1 / 2 页
上一页
下一页
药物
反馈